Bsg guidelines varices treatment

lished guidelines on endoscopy and antiplatelet agents in 2011 [3]. Both guidelines are due for revision, and the BSG and ESGE have cooperated to produce a joint guideline. Since the publica-tion of the previous guidelines there has been an expansion in the use of the newer antiplatelet drugs, and new oral anticoagu-

Variceal assessment This involves assessing the likelihood of varices prior to commencing variceal measures. The assessment is based on the presence of established varices, or risk factors for portal hypertension, such as established cirrhosis, stigmata of chronic liver disease, biochemical and radiological ? ndings. BSG u KDD/^^/KE/E'Z WKZd 2 The Authors This guide has been written in partnership by professional and patient organisations relevant to gastroenterology and hepatology: • British Society of Gastroenterology • British Association for the Study of the Liver • Primary Care Society for Gastroenterology WGO Practice Guideline - Esophageal Varices. Definition: Esophageal varices are portosystemic collaterals — i.e., vascular channels that link the portal venous and the systemic venous circulation. They form as a consequence of portal hypertension (a progressive complication of cirrhosis), preferentially in the submucosa of the lower esophagus. After the treatment of an acute episode of esophageal variceal hemorrhage, endoscopy should be repeated until varices have been eradicated, which typically requires 2 to 4 sessions.46 Optimal intervals for EVL for secondary pro-phylaxishave not been de?nedandrangefrom 2 to8 weeks The role of endoscopy in the management of variceal hemorrhage These updated guidelines on the management of variceal haemorrhage have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under the auspices of the liver section of the BSG. The original guidelines which this document supersedes were written in 2000 and have undergone extensive revision